BioNTech GAAP EPS of -€1.73, revenue of €182.8M; reaffirms FY25 outlook
by
Contributor since / Followers
Contributor since / Followers
2 months ago
- BioNTech press release (NASDAQ:BNTX): Q1 GAAP EPS of -€1.73.
- Revenue of €182.8M (-2.6% Y/Y).
- Cash and cash equivalents plus security investments as of March 31, 2025, reached €15,854.4 million, comprising €10,184.9 million in cash and cash equivalents, €3,542.0 million in current security investments and €2,127.5 million in non-current security investments.